The 59 references in paper A. Salmina V, A. Fursov A., S. Mikhutkina V, S. Shakhmayeva V., N. Mantorova S., А. Салмина Б., А. Фурсов А., С. Михуткина В., С. Шахмаева В., Н. Манторова С. (2008) “Нарушения метаболизма НАД+ в нейрональной дисфункции при критических состояниях // Impaired NAD+ Metabolism in Neuronal Dysfunction in Critical Conditions” / spz:neicon:reanimatology:829

1
Ярилин А. А.Основы иммунологии. М., Медицина; 1999. 144—156.
(check this in PDF content)
2
Соринсон С. Н.Сепсис. Этиология, патогенез, клиника, диагности> ка, терапия. Нижн. Новгород: НГМА; 2000.
(check this in PDF content)
3
Маркова Т. П., Чувиров Г. Н.Лихорадка как симптом. Рус. мед. журн. 2003; 11 (22): 1223.
(check this in PDF content)
4
Бокерия Л. А., Бузиашвили Ю. И., Амбатьева С. Г. и др.Роль цито> хемокинов в развитии когнитивной дисфункции у больных, опери> рованных в условиях искусственного кровообращнеия. Бюл. НЦССХ им. А. Н. Бакулева РАМН 2004; 5 (9Ж): 174—181.
(check this in PDF content)
5
Гаин Ю. М., Леонович С. И., Завада Н. В. и др.Иммунный статус при перитоните и пути его патогенетической коррекции. Минск: ООО Юнипресс; 2001.
(check this in PDF content)
6
Cargill R. S., Thibault L. E.Acute alterations in [Ca2+]I in NG108>15 cells subjected to high strain rate deformation and chemical hypoxia: an in nitro model for neural trauma. J. Neurotrauma 1996; 13: 395—407.
(check this in PDF content)
7
Dirnagl U., Iadecola C., Moskowitz M. A. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999; 22: 391—397.
(check this in PDF content)
8
Mattson M. P., Keller J. N., Begley J. G. Evidence for synaptic apoptosis. Exp. Neurol. 1998; 153 (1): 35—48.
(check this in PDF content)
9
Meloni B. P., Majda B. T., Knuckey N. W. et al.Evaluation of precondi> tioning treatments to protect near>pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Brain Res. 2002; 928: 69—75.
(check this in PDF content)
10
Fox G. B., Fan L., Levasseur R. A., Faden A. I.Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled corti> cal impact brain injury in the mouse. J. Neurotrauma 1998; 15: 599—614.
(check this in PDF content)
11
Hattori K. P., Hurn D., Crain B. J. Cognitive deficits after focal cerebral ischemia in mice. Stroke 2000; 31: 1939—1944.
(check this in PDF content)
12
Flint J.The genetic basis of cognition. Brain 1999; 122: 2015—2031.
(check this in PDF content)
13
Berthelier V., Tixier J. :M., Muller:Steffner H. еt al. Human CD38 is an authentic NAD(P)+glycohydrolase. Biochem. J. 1998; 330: 1383—1390.
(check this in PDF content)
14
Ceni C., Muller:Steffner H., Lund F. et al.Evidence for a intracellular ADP>ribosyl cyclase/NAD glycohydrolase in brain from CD38>defi> cient mice. J. Biol. Chem. 2003; 278 (42): 40670—40678.
(check this in PDF content)
15
Flora A., Franco L., Guida L. et al.Ectocellular CD38>catalyzed syn> thesis and intracellular Ca2+— mobilizing activity of cyclic ADP>ribose. Cell Biochem. Biophys. 1998; 28 (1): 45—62.
(check this in PDF content)
16
Guida L., Bruzzone S., Sturla L. et al. Equilibrative and concentrative nucleoside transporters mediate influx of extracellular cyclic ADP> ribose into 3T3 murine fibroblasts. J. Biol. Chem. 2002; 277 (49): 47097—47105.
(check this in PDF content)
17
Hashii M., Munabe Y., Higashida H.cADP>ribose potentiates cytosolic Ca2+elevation and Ca2+entry via L>type voltage>activated Ca2+chan> nels in NG108>15 neuronal cells. Biochem. J. 2000; 345: 207—215.
(check this in PDF content)
18
Higashida H., Hashii M., Yokoyama S. et al.Cyclic ADP>ribose as a sec> ond messenger revisited from a new aspect of signal transduction from receptors to ADP>ribosyl cyclase. Phramacol. Therapeutic. 2001; 90: 283—296.
(check this in PDF content)
19
Bergmann F., U. Keller B.Impact of mitochondrila inhibition on excitability and cytosolic Ca2+levels in brainstem motoneurons from mouse. J. Physiol. 2003; 555: 45—59.
(check this in PDF content)
20
Alano C. C., Ying W., Swanson R. A. Poly(ADP>ribose) polymerase>1> mediated cell death in astrocytes requires NAD+depletion and mito> chondrial permeability transition. J. Biol. Chem. 2004; 279 (18): 18895—18902.
(check this in PDF content)
21
Di Lisa F., Bernardi P.Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol. Cell. Biochem. 1998; 184: 379—391.
(check this in PDF content)
22
Weeber E. J., Levy M., Sampson M. J. et al.The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. J. Biol. Chem. 2002; 277 (21): 18891—18897.
(check this in PDF content)
23
Lambert C., Landau A. M., Desbarats J.Fas>beyond death: a regenerative role for Fas in the nervous system. Apoptosis 2003; 8: 551—562.
(check this in PDF content)
24
Ly J. D., Grubb D. R., Lawen A.The mitochondrial membrane potential in apoptosis; an update. Apoptosis 2003; 8: 115—128.
(check this in PDF content)
25
Friedlender R. M.Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 2003; 348: 1365—1375.
(check this in PDF content)
26
Ran Z:H., Rayet B., Rommelaere J.Parvovirus H1>induced cell death: influence of intracellular NAD consumption on the regulation of necro> sis and apoptosis. Virus Res. 1999; 65: 161—174.
(check this in PDF content)
27
Aksoy P., White T., Thompson M.Regulation of intracellular levels of NAD: a novel role for CD38. Biochem. Biophys. Res. Comm. 2006; doi (10): 1016.
(check this in PDF content)
28
Berger F., Lau C., Dahlmann M.Subcellular compartmentation and dif> ferent catalytic properties of three human nicotinamide mononu> cleotide adenylyltransferase isoforms. J. Biol. Chem. 2005; 280 (43): 36334—36341.
(check this in PDF content)
29
Jorcke D., Ziegler M., Herrero:Yraola A. еt al. Enzymic, cysteine>specific ADP>ribosylation in bovine liver mitochondria. Biochem. J. 1998; 332: 189—193.
(check this in PDF content)
30
Virag L., Szabo C.The therapeutic potential of poly(ADP>ribose) poly> merase inhibitors. Pharmacol. Rev. 2002; 54 (3): 375—430.
(check this in PDF content)
31
Bruzzone S., Verderio C., Schenk U. et al.Glutamate>mediated overex> pression of CD38 in astrocytes cultured with neurons. J. Neurochem. 2004; 89: 264.
(check this in PDF content)
32
Hatton G. L. Glial>neuronal interactions in the mammalian brain. Advan. Physiol. Edu. 2002; 26: 225—237.
(check this in PDF content)
33
Magistretti P. J. Neuron>glia metabolic coupling and plasticity. J. Exp. Biol. 2006; 209: 2304—2311.
(check this in PDF content)
34
Ceni C., Pochon N., Villaz M. et al.The CD38>independent ADP>ribosyl cyclase from mouse brain synaptosomes: a comparative study of neonate and adult brain. Biochem. J. 2006; 395: 417—426.
(check this in PDF content)
35
Mizuguchi M., Otsuka N., Sato M. et al.Neuronal localization of CD38 antigen in the human brain. Brain Res. 1995; 697: 235—240.
(check this in PDF content)
36
Zocchi E., Franco L., Guida L. et al. NAD+>dependent internalization of the transmembrane glycoprotein CD38 in human Namalwa B cells. FEBS Lett. 1996; 396: 327>332.
(check this in PDF content)
37
Zocchi E., Usai C., Guida L. e al.Ligand>induced internalization of CD38 results in intracellular Ca2+mobilization: role of NAD+transport across cell membranes. FASEB J. 1999; 13: 273—283.
(check this in PDF content)
38
Tohgo A., Takasawa S., Noguchi N. et al. Essential cysteine residues for cyclic ADP>ribose synthesis and hydrolysis by CD38. J. Biol. Chem. 1994; 269: 28555—28557.
(check this in PDF content)
39
Higashida H., Robbins J., Egorova A. et al. Nicotinamide>adenine dinu> cleotide regulates muscarinic receptor>coupled K+(M) channels in rodent NG108>15 cells. J. Physiol. 1995; 482 (2): 317—323.
(check this in PDF content)
40
Meyer D. A., Carta M., Partridge L. D. et al.Neurosteroids enhance spon> taneous glutamate release in hippocampal neurons: possible role of metabotropic 1>like receptors. J. Biol. Chem. 10. 1074; jbc. M202592200.
(check this in PDF content)
41
Dogan S., Deshpande D. A., Kannan M. S. et al.Changes in CD38 expression and ADP>ribosyl cyclase activity in rat myometrium during pregnancy: influence of sex steroid hormones. Biol. Reprod. 2004; 71: 97—103.
(check this in PDF content)
42
Liao S. L., Chen W. Y., Chen C. J.Estrogen attenuates tumor necrosis factor>alpha expression to provide ischemic neuroprotection in female rats. Neurosci. Lett. 2002; 330: 159—162.
(check this in PDF content)
43
Kii N., Adachi N., Liu K. et al. Acute effects of 17beta>estradiol on oxida> tive stress in ischemic rat striatum. J. Neurosurg. Anesthesiol. 2005; 17: 27—32.
(check this in PDF content)
44
Pawlikowska L., Cottrell S. E., Harms M. B. et al. Extracellular synthesis of cADP>ribose from nicotinamide>adenine dinucleotide by rat cortical astrocytes in culture. J. Neurosci. 1996; 16(17): 5372—5381.
(check this in PDF content)
45
Hotta T., Asai K., Fujita T. et al. Membrane>bound form of ADP>ribosyl cyclase in rat cortical astrocytes in culture. J. Neurochem. 2000; 74 669—675.
(check this in PDF content)
46
Wall K., Klis M., Kornett A. et al.Inhibition of the intrinsic NAD+ gly> cohydrolase activity of CD38 by carbocyclic NAD analogues. Biochem. J. 1998; 335: 631—636.
(check this in PDF content)
47
Verderio C., Matteoli M.ATP mediates calcium signaling between astro> cytes and microglial cells: modulation by IFN>gamma. J. Immunol. 2001; 166: 6383—6391.
(check this in PDF content)
48
Wilson H. L., Dipp M., Thomas J. T. et al.ADP>ribosyl cyclase and cyclic ADP>ribose hydrolase act as redox sensors. J. Biol. Chem. 2001; 276 (14): 1180—1188.
(check this in PDF content)
49
Sun L. A., Adebanjo O. A., Koval A. et al.Novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+signaling via CD38/ADP>ribosyl cyclase a putative intracellular NAD+sensor. FASEB J. 2002; 16: 302—314.
(check this in PDF content)
50
Ziegler M., Jorcke D., Schweiger M. Identification of bovine liver mito> chondrial NAD+>glycohydrolase as ADP>ribosyl cyclase. Biochem. J. 1997; 326: 401—405.
(check this in PDF content)
51
Mills J. C., Stone N. L., Pittman R. N.Extranuclear apoptosis: the role of the cytoplasm in the execution phase. J. Cell. Biol. 1999; 146 (4): 703—708.
(check this in PDF content)
52
Ying W., Garnier P., A. Swanson R.NAD+as a metabolic link between DNA damage and cell death. J. Neurosci. Res. 2005; 79: 216—223.
(check this in PDF content)
53
Vlassenko A. G., Rundle M. M., Raichle M. E. et al.Regulation of blood flow in activated human brain by cytosolic NADH/NAD+ratio. PNAS 2006; 103: 1964—1969.
(check this in PDF content)
54
Yau J. L. W., Noble J., Hibberd C. et al.Chronic treatment with the anti> depressant amitriptyline prevents impairments in water maze learning in aging rats. J. neurosci. 2002; 22 (4): 1436—1442.
(check this in PDF content)
55
Shuto S., Matsuda A. Chemistry of cyclic ADP>ribose and its analogs. Curr. Med. Chem. 2004; 11 (7): 827—845.
(check this in PDF content)
56
Yang J., Adams J. D. Jr.Structure activity relationships for nicotinamide for the treatment of stroke. Lett. Drug Design Discovery 2004; 1: 58—65.
(check this in PDF content)
57
Stoffel:Wagner B.Neurosteroid metabolism in the human brain. Eur. J. Endocrinol. 2001; 145: 669—679.
(check this in PDF content)
58
Willets J. M.Neurotoxicity of nicotinamide derivatives: their role in the ethiology of Parkinson's disease. Biochem. Soc. Trans. 1993; 3: 299S.
(check this in PDF content)
59
Salmina A. B., Olovyannikova R. Ya., Noda M., Higashida H.NAD+ metabolism and ADP>ribosyl cyclase as targets for central nervous sys> tem therapy. Current Medicinal Chemistry 2006; 6: 193—210. Поступила 08. 06. 07
(check this in PDF content)